Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Race executes global license agreement with City of Hope to access FTO IP 2023-07-10 19:30
Rx-360 Expands Trademark Portfolio to Japan 2023-07-10 18:00
Atlas Associates Clinic Introduces Convenient House Calls for Enhanced Patient Care 2023-07-10 16:07
HOYA Group PENTAX Medical Established Manufacturing, R & D and Service Center in China 2023-07-10 16:00
Calling Bright Minds in Southeast Asia, Bio Farma and MIT Hacking Medicine is Set to Revolutionize Healthcare with a 4-Day Hackathon 2023-07-10 15:19
BRONCUS COMPLETES THE FIRST CASE OF REGISTERED CLINICAL TRIALS OF ITS TARGETED LUNG DENERVATION RADIOFREQUENCY ABLATION SYSTEM 2023-07-10 12:56
SIAF: Disrupted epithelial barriers as a predictor of severe COVID-19 development 2023-07-10 11:13
RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors 2023-07-10 10:24
Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services 2023-07-07 21:00
280 Bio receives IND approval from the FDA for YL-17231 2023-07-07 20:00
Kexing Biopharm Makes it into China's Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years 2023-07-07 19:43
Transcenta Received Approvals from China CDE and South Korea MFDS to Initiate TranStar 301 Global Phase III Pivotal Trial of Osemitamab (TST001) 2023-07-07 15:52
Forge Stronger Partnership for Advanced ADC Development! GeneQuantum Healthcare and Aimed Bio collaborate to develop five innovative ADC drugs 2023-07-07 10:19
Hexvix®, A Diagnostic Drug for Bladder Cancer of Asieris has Completed the Phase III bridging trial Enrollment 2023-07-06 18:33
Genesis MedTech Receives Approval for Launch in China for ArtiSential™ 2023-07-06 18:00
Registrational Pivotal Phase III Study of Olverembatinib for the First-Line Treatment of Patients with Ph+ ALL Approved by the CDE in China 2023-07-06 10:38
MGI's DNBSEQ-T7* Receives Approval for Clinical Use in South Korea 2023-07-06 09:00
Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure 2023-07-06 07:25
Brii Biosciences Provides Latest Clinical Development and Corporate Updates 2023-07-06 07:19
United Imaging, Kicking off a Birthday Celebration of Five Years in the U.S. Market, Will Debut Three New Scanners at AHRA 2023-07-06 00:00
1 177 178 179 180 181 970